Article info

Download PDFPDF
Extended report
Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers

Authors

  • Karin Hellgren Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet at Karolinska University Hospital, Stockholm, Sweden Clinical Epidemiology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Lene Dreyer Department of Rheumatology, Herlev and Gentofte University Hospital, Hellerup, Denmark The Parker Institute, Bispebjerg and Frederiksberg, University of Copenhagen, Copenhagen, Denmark PubMed articlesGoogle scholar articles
  • Elizabeth V Arkema Clinical Epidemiology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Bente Glintborg Department of Rheumatology, Herlev and Gentofte University Hospital, Hellerup, Denmark The Parker Institute, Bispebjerg and Frederiksberg, University of Copenhagen, Copenhagen, Denmark PubMed articlesGoogle scholar articles
  • Lennart T H Jacobsson Department of Rheumatology and Inflammation Research, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden PubMed articlesGoogle scholar articles
  • Lars-Erik Kristensen The Parker Institute, Bispebjerg and Frederiksberg, University of Copenhagen, Copenhagen, Denmark Department of Rheumatology, Lund University Hospital, Lund, Sweden PubMed articlesGoogle scholar articles
  • Nils Feltelius Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet at Karolinska University Hospital, Stockholm, Sweden Swedish Medical Products Agency, Uppsala, Sweden PubMed articlesGoogle scholar articles
  • Merete Lund Hetland DANBIO Registry, Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet, Glostrup, Denmark Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark PubMed articlesGoogle scholar articles
  • Johan Askling Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet at Karolinska University Hospital, Stockholm, Sweden Clinical Epidemiology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Karin Hellgren, Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet at Karolinska University Hospital, 171 76 Stockholm, Sweden; karin.hellgren{at}karolinska.se
View Full Text

Citation

Hellgren K, Dreyer L, Arkema EV For the ARTIS Study Group, For the DANBIO Study Group, et al
Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers

Publication history

  • Received January 27, 2016
  • Revised April 3, 2016
  • Accepted April 9, 2016
  • First published May 4, 2016.
Online issue publication 
December 09, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.